Showing results (631-640 of 1,008) with videos related to

Sort By:
Pageof 101
Cardiovascular Therapeutics|November 6, 2025
Is Carvedilol Effective in Preventing and Modulating Concentric Cardiac Remodelling? A Comprehensive Systematic Review and Meta-AnalysesAlice Valeria Wiyono, Azizah Puspitasari Ardinal
Cardiovascular Therapeutics|November 10, 2025
Association Between Blood Cadmium Levels and Heart Failure Risk: Insights From NHANES 2009-2014Yong He, Hongkun Wu, Yongjin Luo, et al.
Cardiovascular Therapeutics|August 11, 2025
Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve DiseaseYuxing Wang, Ming Yu, Song Yang, et al.
Cardiovascular Therapeutics|October 15, 2025
Optimization of Clinical Trial Design and Decision-Making for Heart Failure with Preserved Ejection Fraction (HFpEF): A Meta-Analysis Based on a Placebo Response ModelXiaoya Chen, Juan Yang, Ling Xu, et al.
Cardiovascular Therapeutics|August 5, 2025
Eplerenone Inhibits Atrial Autonomic Nerve Remodeling in Atrial Fibrillation Through ERK1/2 MAPK PathwayWei Xu, Cheng-Yuan Yu, Ding-Yu Wang, et al.
Cardiovascular Therapeutics|April 10, 2013
Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartanNajah R Hadi, Nasser Ghaly Yousif, Mohammed S Abdulzahra, et al.
Cardiovascular Therapeutics|May 8, 2013
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillationGerrit Frommeyer, Peter Milberg, Timo Uphaus, et al.
Cardiovascular Therapeutics|February 13, 2013
A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalantEnrico Vizzardi, Francesca Salghetti, Ivano Bonadei, et al.
Cardiovascular Therapeutics|March 14, 2013
Mulberry leaf diet protects against progression of experimental autoimmune myocarditis to dilated cardiomyopathy via modulation of oxidative stress and MAPK-mediated apoptosisSomasundaram Arumugam, Sayaka Mito, Rajarajan A Thandavarayan, et al.
Cardiovascular Therapeutics|March 14, 2013
State of play of pharmacogenetics and personalized medicine in heart failureHelen M Parry, Alex S F Doney, Colin N A Palmer, et al.
Pageof 101